- NWHN endorses the Women’s March on Washington
January 6, 2017
The National Women’s Health Network supports the mission of the Women’s March, and is proud to join in this effort to send a bold message to the new government that women’s rights are human rights. We are inspired by the hundreds of thousands of supporters of women’s rights who have spontaneously engaged in the March. ...
- Taking a Principled Approach to the Provision of LARCs
December 9, 2016
By Monica Simpson and Cindy Pearson
There has been increased attention and funding in recent years for long-acting reversible contraceptive methods (LARCs). While LARCs are part of a well-balanced mix of contraceptive options, there are concerning practices when it comes to who is targeted for long-acting methods and the way in which counseling is provided.
The debate ...
- NWHN-SisterSong Joint Statement of Principles on LARCs
November 14, 2016
Over the last few years, there has been a surge in the promotion of long-acting reversible contraceptives (LARCs) such as intrauterine devices (IUDs) and implants like Nexplanon. LARCs are highly effective in preventing pregnancy, last for an extended period of time, and work without user action once they are inserted. These characteristics make them a ...
- Letter to the Editor: Why Some Women are Afraid to Treat Osteoporosis
October 24, 2016
As a longtime Washington Post subscriber and women’s health advocate, I was disappointed to see “Why some women are afraid to treat osteoporosis” published on your website Tuesday.
The author, in an attempt to emphasize the importance of appropriately treating osteoporosis, dismisses the very real and serious risks of bisphosphonate use. Bisphosphonates can be effective in treating ...
- 10 Years after HPV Vaccines’ Approval, Where Do We Stand?
September 6, 2016
Merck’s newest HPV-focused commercials are coming under fire for shaming and guilting parents into vaccinating their children against HPV. The unbranded commercials, that started airing nationally and on Hulu in July, open with a young women stating: “I have cervical cancer, from an infection – Human papillomavirus.” Over photos, presumably of the woman as a ...
- Plan B & Weight: Is it still right for me?!
May 24, 2016
The condom broke. Or you missed a pill. As you learn about your options. you come across information that states Plan B doesn’t work for people who weigh more than 165 pounds. That’s because in 2011, some studies indicated that Plan B Emergency Contraception (containing levonorgestrel) wasn’t effective for women over a certain weight. This ...
- NWHN Wishes You a Happy Women’s History Month!
March 22, 2016
“Who runs the world?” If you said anything other than “Girls!” go step outside and bring yourself up to speed, my dear Cro-Magnon. Once you’ve caught up, feel free to cheer loudly and join us in the 21st century as we celebrate Women’s History Month. That’s right! March is Women’s History Month! That means it ...
- Déjà Vu All Over Again: #HandsOffMyBC!
March 14, 2016
Once again, a provision of the Affordable Care Act (ACA) is being challenged before the Supreme Court, with oral arguments for Zubik v. Burwell scheduled for March 23. And once again the question at the heart of the case is whether women will have access to the contraception coverage assured them by the ACA even ...
- Get Your Sleep On
March 7, 2016
We’ve all been there. The lights are low, alarms have been set. You’ve showered and, if you’re anything like me, did an interpretive dance to Outkast’s “So Fresh, So Clean”. Now you’re snuggled up in bed, preparing for a well-deserved sleep to consume your semi-weary body. Yet 20 minutes later, you find yourself staring up ...
- Flibanserin Update: Health and Safety Concerns Continue to be Profound
March 2, 2016
On Monday, JAMA Internal Medicine published a systematic review evaluating the safety and efficacy of flibanserin, a drug purported to treat Hypoactive Sexual Desire Disorder (HSDD) in premenopausal women.
Unsurprisingly, the researchers reported that flibanserin’s benefits are “are marginal, particularly when taking into account the concurrent occurrence of adverse events.” Further, the researchers reported “the ...